What Do Oncologists Say about Chemotherapy at the Very End of Life? Results from a Semiqualitative Survey

被引:17
作者
Behl, Deepti [1 ]
Jatoi, Aminah [1 ]
机构
[1] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA
关键词
CANCER CARE; QUALITY; AGGRESSIVENESS; INDICATORS;
D O I
10.1089/jpm.2009.0414
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aim: This study elicited oncologists' insights into published statistics that 20% of cancer patients receive chemotherapy within 2 weeks of death and that the median survival between chemotherapy administration and death is 37 days. Subjects and methods: A semiqualitative survey was developed to enable respondents to provide anonymous, write-in comments on the statistics above. This survey was sent electronically on two separate occasions to oncologists in the upper midwestern United States. Qualitative methods were used to analyze data. Results: A total of 422 oncology health-care providers were sent the survey, and 61 responded. Nine themes emerged: 1) these decisions are strongly patient-driven; 2) newer agents are driving the decision to continue with cancer treatment; 3) financial incentives on the part of the medical community explain these high rates; 4) health-care reform is necessary; 5) even a small chance of patient benefit justifies this practice; 6) this practice is detrimental to patients because it precludes the initiation of hospice services; 7) others may be prescribing in this manner, but "not us''; 8) these issues are complicated, revolve around society values, and the oncologist alone cannot claim responsibility for such high rates of chemotherapy administration; and 9) there exist barriers to end-of-life discussions. Conclusion: Many oncologists are in fact reluctant to prescribe chemotherapy at the end of life, and the complexity of this topic underscores the potential for oncologists and palliative care providers to collaborate in an effort to provide cancer patients the best care at the very end of life.
引用
收藏
页码:831 / 835
页数:5
相关论文
共 10 条
[1]   Indicators of poor quality end-of-life cancer care in Ontario [J].
Barbera, L ;
Paszat, L ;
Chartier, C .
JOURNAL OF PALLIATIVE CARE, 2006, 22 (01) :12-17
[2]  
Douglass Mark A, 2009, J Opioid Manag, V5, P169
[3]   Trends in the aggressiveness of cancer care near the end of life [J].
Earle, CC ;
Neville, BA ;
Landrum, MB ;
Ayanian, JZ ;
Block, SD ;
Weeks, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :315-321
[4]   Aggressiveness of cancer care near the end of life: Is it a quality-of-care issue? [J].
Earle, Craig C. ;
Landrum, Mary Beth ;
Souza, Jeffrey M. ;
Neville, Bridget A. ;
Weeks, Jane C. ;
Ayanian, John Z. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (23) :3860-3866
[5]   How to read a paper - Papers that go beyond numbers (qualitative research) [J].
Greenhalgh, T ;
Taylor, R .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7110) :740-743
[6]  
HONG NJL, 2009, J INTERPROF CARE, V20, P1
[7]   Career Longevity in Clinical Pediatric Emergency Medicine [J].
Ros, Simon P. ;
Scheper, Ryan .
PEDIATRIC EMERGENCY CARE, 2009, 25 (08) :487-488
[8]  
Russell Cynthia K, 2003, Evid Based Nurs, V6, P36
[9]   Developing Quality Indicators for Cancer End-of-Life Care Proceedings From a National Symposium [J].
Seow, Hsien ;
Snyder, Claire F. ;
Shugarman, Lisa R. ;
Mularski, Richard A. ;
Kutner, Jean S. ;
Lorenz, Karl A. ;
Wu, Albert W. ;
Dy, Sydney M. .
CANCER, 2009, 115 (17) :3820-3829
[10]   Comparison of Prospective and Retrospective Indicators of the Quality of End-of-Life Cancer Care [J].
Setoguchi, Soko ;
Earle, Craig C. ;
Glynn, Robert ;
Stedman, Margaret ;
Polinski, Jennifer M. ;
Corcoran, Colleen P. ;
Haas, Jennifer S. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5671-5678